Beauty Rediscovered

   

         call us today : 004 021 221 95 58
 

                                                         make now a reservation 

Home

wat's new

 


 


 

Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men

A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. Due to these events, the treatment phase of the trial was stopped. The study was supported by a grant to Shalender Bhasin, M.D., at Boston Medical Center from the National Institute on Aging (NIA), part of the National Institutes of Health.
NIH-Supported ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
Aiming for Near-Normal Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control. These findings are from the NIH-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Although intensive treatment produced some beneficial changes, this approach was reported in 2008 to increase death rates.
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National HIV Testing Day June 27, 2010

On National HIV Testing Day, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, urges everyone between the ages of 13 and 64 years to be tested for HIV at least once in their lifetime in keeping with the recommendation of the Centers for Disease Control and Prevention (CDC).
Intervention Lowered Obesity Rate in Youth at High Diabetes Risk, HEALTHY Study Finds

An intervention in middle schools lowered the obesity rate in students at highest risk for type 2 diabetes, those who started out overweight or obese in sixth grade, an NIH-funded study has found.
NIBIB and the Indian Department of Biotechnology Collaborate to Develop Low-Cost Medical Devices

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, announced the availability of supplemental funding for eligible NIBIB-supported research grants to facilitate collaborative work among researchers in the United States and India.
  • health category:

User login

Romania Spa Packages

designed by